| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.35 | 0.04 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |